MedTrace Logo

Prevalence of and Factors Associated With Metabolic Syndrome in Schizophrenia

NCT01587521 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2016-07-28

No results posted yet for this study

Summary

Patients with schizophrenia are more likely to have metabolic syndrome compared to general population. The criterion for metabolic syndrome in Asian people including: elevated waist circumference (male ≥ 90cm, female ≥ 80cm), elevated triglycerides ≥ 150mg/dL, reduced HDL cholesterol: male \< 40mg/dL, female \< 50mg/dL, elevated blood pressure: ≥ 130/85 mmHg, elevated fasting glucose: ≥ 100mg/dL. Several factors have been found to be associated with metabolic syndrome in schizophrenia, e.g. age, antipsychotic drugs, smoking, family history of metabolic disorder, stress, and quality of life.

However, little is known about the prevalence of and factors associated in Asian. This study aimed to:

1. Identify the prevalence of metabolic syndrome in patients with schizophrenia.
2. Identify the factors associated with metabolic syndrome in patients with schizophrenia.

Conditions

Sponsors & Collaborators

  • Chiang Mai University

    lead OTHER

Principal Investigators

  • Sirijit Suttajit, MD. MSc. · Chiang Mai University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01587521 on ClinicalTrials.gov